IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q3 2019 Holdings

Filed 2019-11-14 | 14 holdings | $158.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Personalis(PSNL)Common71535D106$79.9K5,449,29450.5%
Crispr(CRSP)NAMEN AKTH17182108$25.7K628,39816.3%
Exicure(XCUR)Common30205M101$15.8K6,250,00010.0%
SientraCommon82621J105$15.5K2,390,8439.8%
SolenoCommon834203200$6.9K4,669,2724.4%
ParatekCommon699374302$4.5K1,041,1312.9%
Verona(VRNA)SPONDS ADR925050106$4.1K901,9432.6%
Aeglea(AGLEUSD)Common00773J103$1.8K240,5001.2%
Chiasma(CHMA)Common16706W102$1.8K370,6711.2%
ObsevaCommonH5861P103$73187,9990.5%
Cymabay(CBAYUSD)Common23257D103$670131,0360.4%
ProteonCommon74371L109$5252,017,8720.3%
Sierra OncologyCommon82640U107$83216,6670.1%
OcugenCommon43358V109$207,1110.0%